Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
67%(4 trials)

Phase Distribution

Ph phase_3
4
67%
Ph phase_2
2
33%

Phase Distribution

0

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
4(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (33.3%)
Phase 34 (66.7%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia

NCT05728944
completedphase_3

Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia

NCT05656027
completedphase_3

Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia

NCT06045299
completedphase_3

Phase 3 Safety Study for the Treatment of Presbyopia Subjects

NCT05753189
completedphase_2

Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia

NCT05294328
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05728944Phase 3

Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia

Completed
NCT05656027Phase 3

Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia

Completed
NCT06045299Phase 3

Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia

Completed
NCT05753189Phase 3

Phase 3 Safety Study for the Treatment of Presbyopia Subjects

Completed
NCT05294328Phase 2

Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia

Completed
NCT05431543Phase 2

Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6